Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 755739
                    [Title] => Implications of biosimilars in clinical practice tackled
                    [Summary] => 
Pharmaceutical company Roche recently conducted a medical symposium where it invited doctors from various specialties such as medical oncology, rheumatology, endocrinology, gastroenterology, and nephrology for a scientific meeting about the opportunities and challenges of biotherapeutics in clinical practices.
                    [DatePublished] => 2011-12-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 267989
                    [Title] => Changing technologies benefit IBD sufferers
                    [Summary] => Scientists’ understanding of inflammatory bowel disease (IBD) has increased recently as a result of some interesting developments. As AGA member, of the Digestive Health Center of Michigan states, not only have there been "tremendous changes in the last three to five years," we can also expect great changes in the near future. Doctor calls this a "very optimistic time" for the diagnosis and treatment of IBD. So what’s on the horizon for those who suffer from Crohn’s disease and ulcerative colitis?
                    [DatePublished] => 2005-01-30 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

BIOLOGIC

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 755739
                    [Title] => Implications of biosimilars in clinical practice tackled
                    [Summary] => 
Pharmaceutical company Roche recently conducted a medical symposium where it invited doctors from various specialties such as medical oncology, rheumatology, endocrinology, gastroenterology, and nephrology for a scientific meeting about the opportunities and challenges of biotherapeutics in clinical practices.
                    [DatePublished] => 2011-12-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 267989
                    [Title] => Changing technologies benefit IBD sufferers
                    [Summary] => Scientists’ understanding of inflammatory bowel disease (IBD) has increased recently as a result of some interesting developments. As AGA member, of the Digestive Health Center of Michigan states, not only have there been "tremendous changes in the last three to five years," we can also expect great changes in the near future. Doctor calls this a "very optimistic time" for the diagnosis and treatment of IBD. So what’s on the horizon for those who suffer from Crohn’s disease and ulcerative colitis?
                    [DatePublished] => 2005-01-30 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Implications of biosimilars in clinical practice tackled

December 8, 2011 - 12:00am

Pharmaceutical company Roche recently conducted a medical symposium where it invited doctors from various specialties such as medical oncology, rheumatology, endocrinology, gastroenterology, and nephrology for a...

Science and Environment

Changing technologies benefit IBD sufferers

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | January 30, 2005 - 12:00am

Scientists’ understanding of inflammatory bowel disease (IBD) has increased recently as a result of some interesting developments. As AGA member, of the Digestive Health Center of Michigan states, not only have...

Opinion